These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 19593187

  • 21. Switching between clozapine and risperidone treatment.
    Gardner DM, Baldessarini RJ, Benzo J, Zarate CA, Tohen M.
    Can J Psychiatry; 1997 May; 42(4):430-1. PubMed ID: 9161773
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O, Kurtz G, Müller-Felber W, Modell S.
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [Abstract] [Full Text] [Related]

  • 24. Clozapine-Valproate Adverse Drug Reactions and the Need for a Clozapine Rechallenge Case File.
    Kanofsky JD, Woesner ME.
    Prim Care Companion CNS Disord; 2017 Jan 05; 19(1):. PubMed ID: 28102977
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
    Kosehasanogullari SG, Akdede B, Akvardar Y, Akan M, Tunca Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1147-8. PubMed ID: 17513032
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Toxic delirium with low-dose clozapine.
    Wilkins-Ho M, Hollander Y.
    Can J Psychiatry; 1997 May 30; 42(4):429-30. PubMed ID: 9161772
    [No Abstract] [Full Text] [Related]

  • 29. Restarting clozapine: a case report.
    Barrons E, Johnson E, Nynkowski P.
    Psychiatr Serv; 1996 Jan 30; 47(1):92. PubMed ID: 8925356
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment of bipolar disorders].
    Schmauss M, Messer T.
    MMW Fortschr Med; 2009 Mar 26; 151(13):74-8. PubMed ID: 19504825
    [No Abstract] [Full Text] [Related]

  • 31. Glycopyrrolate for clozapine-induced sialorrhea.
    Duggal HS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1546-7. PubMed ID: 17614181
    [No Abstract] [Full Text] [Related]

  • 32. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN, Jiloha RC.
    Aust N Z J Psychiatry; 2005 Oct 01; 39(10):947-8. PubMed ID: 16168023
    [No Abstract] [Full Text] [Related]

  • 33. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.
    Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM.
    Psychiatr Q; 2006 Oct 01; 77(1):81-95. PubMed ID: 16397757
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Esophageal dysfunction in two patients after clozapine treatment.
    McCarthy RH, Terkelsen KG.
    J Clin Psychopharmacol; 1994 Aug 01; 14(4):281-3. PubMed ID: 7962688
    [No Abstract] [Full Text] [Related]

  • 36. Continuation of clozapine following mild myocarditis.
    Ronaldson KJ, Fitzgerald PB, Taylor AJ, McNeil JJ.
    Aust N Z J Psychiatry; 2012 Sep 01; 46(9):910-1. PubMed ID: 22956573
    [No Abstract] [Full Text] [Related]

  • 37. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S, Maccabee N, Kaushik S, Lindenmayer JP.
    J Clin Psychiatry; 2009 Sep 01; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract] [Full Text] [Related]

  • 38. Deconstructing a medication regimen.
    Preskorn SH.
    J Psychiatr Pract; 2008 Mar 01; 14(2):114-8. PubMed ID: 18360197
    [No Abstract] [Full Text] [Related]

  • 39. [Iatrogenic psychiatric-like symptoms recognition].
    Demily C, Chouinard VA, Chouinard G.
    Encephale; 2010 Oct 01; 36(5):417-24. PubMed ID: 21035632
    [Abstract] [Full Text] [Related]

  • 40. Rhabdomyolysis associated with clozapine treatment in a patient with decreased calcium-dependent potassium permeability of cell membranes.
    Koren W, Koren E, Nacasch N, Ehrenfeld M, Gur H.
    Clin Neuropharmacol; 1998 Oct 01; 21(4):262-4. PubMed ID: 9704170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.